Is Binah Capital Group, Inc. (BCG) a Buy, Sell, or Hold?
NASDAQ : BCG
Binah Capital Group, Inc.
$1.37 USD
$0 (0.0%)
- Volume
- 2.31K
- Average Volume
- 52.57K
- Market Capitalization
- $23.03M
- P/E Ratio
- 11.72
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.44
- Year Low
- $1.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.26
- Current Ratio
- $0.85
Company Overview
NASDAQ
Craig Michael Gould
Asset Management
Financial Services
BCG
150
US
USD
Liquidity Metrics
1.26
0.85
0.85
0.37
0.26
Sales & Valuation
$182.04M
0.13
1.12
5.04
0.27
Profitability
$0.04
$2.31M
1.74%
2.08%
30.08%
4.45%
P/E Metrics
11.72
0.02
0.02
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
2.65
7/9
-$4.29M
$71.25M
$50.83M
$6.37M
Key Metrics (TTM)
$38.13M
0.21
5.40
0.85
30.08%
15.88%
13.93%
19.99%
$2.28
-26 days
Company Executives
| Name | Title |
|---|---|
| David Shane | Chief Financial Officer & Director |
| Kathrine Flouton | President & Chief Executive Officer of Purshe Kaplan Sterling Investments, Inc. |
| Craig Michael Gould | Chief Executive Officer & Chairman of the Board |
| Roger Farrell Leibowitz | Chief Financial Officer of Cabot Lodge Securities, LLC |
| Ryan Marcus | Chief Business Development & Engagement Officer |
Poll Results
No votes yet today — be the first to share your view!
About Binah Capital Group, Inc. (NASDAQ:BCG) Stock
Binah Capital Group, Inc. (BCG), along with its associated companies, is active in the wealth management sector. The firm furnishes financial advisors with comprehensive execution capabilities for a broad spectrum of investments, including equities, fixed-income securities, exchange-traded funds (ETFs), and options. Furthermore, it supplies essential support services to these advisors, encompassing research, regulatory compliance, supervisory guidance, and accounting. BCG's product portfolio also features mutual funds and various insurance solutions, in addition to specialized alternative investments like non-traded real estate investment trusts (REITs), unit trusts, and both fixed and variable annuities. Established in 2016, Binah Capital Group maintains its corporate headquarters in Alba ... ny, New York, and operates as a subsidiary of MHC Securities, LLC.
BCG CEO: AI adoption now as high on CEOs' agenda as profits
2026-07-22 08:16:30
Christoph Schweizer, CEO of Boston Consulting Group (BCG), tells CNBC's Squawk Box Europe that AI adoption is now as much on the minds of global CEOs as sales and profits, as businesses begin to understand the operational, cultural and skills-related challenges of integrating the technology into the workplace. Schweizer also discusses how he expects AI to reshape the global workforce, saying around 50% of jobs will fundamentally change, while only 10% to 15% are likely to be replaced entirely.
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-06-15 10:00:00
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
2026-06-11 07:06:00
SAN FRANCISCO--(BUSINESS WIRE)--Transcend, the autonomous "can I use this data?" platform that powers every data decision to scale customer growth, released The 2026 State of Customer Data in the World of AI, a report drawn from a survey of 228 senior IT and business leaders at enterprises with 5,000 or more employees.The findings reveal a widening gap between enterprise AI ambition and the data infrastructure required to support it. Despite Boston Consulting Group (BCG) projections that $2 tril.
2026-05-29 07:00:00
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
2026-05-28 22:00:00
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the
2026-05-28 21:18:00
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca's IMFINZI® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC). The approval by the Food and Drug Administration (FDA) is based on positive results from the POTOMAC Phase III trial which were presented at the European Society for Medical Oncology (ESMO) Congress 2025 and s.
2026-05-25 09:00:00
TVS Motor Company, part of TVS VENU, has been ranked #1 globally in the âDurable Consumer Goods' category in the annual âBest Stocks in the World', ranking
2026-05-19 21:00:00
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration has accepte
Frequently Asked Questions
-
What is the current Binah Capital Group, Inc. (BCG) stock price?
-
Binah Capital Group, Inc.(NASDAQ:BCG) stock price is $1.37 in the last trading session. During the trading session, BCG stock reached the peak price of $3.44 while $1.36 was the lowest point it dropped to. The percentage change in BCG stock occurred in the recent session was 0.0% while the dollar amount for the price change in BCG stock was $0.
-
BCG's industry and sector of operation?
-
The NASDAQ listed BCG is part of Asset Management industry that operates in the broader Financial Services sector.
-
Who are the executives of BCG?
-
David Shane | Chief Financial Officer & Director
Kathrine Flouton | President & Chief Executive Officer of Purshe Kaplan Sterling Investments, Inc.
Craig Michael Gould | Chief Executive Officer & Chairman of the Board
Roger Farrell Leibowitz | Chief Financial Officer of Cabot Lodge Securities, LLC
Ryan Marcus | Chief Business Development & Engagement Officer -
How many employees does BCG have?
-
Number of BCG employees currently stands at 150. BCG operates from 80 State Street, Albany, NY 12207, US.
-
Link for BCG official website?
-
Official Website of BCG is: https://www.binahcap.com
-
How do I contact BCG?
-
BCG could be contacted at phone #212-404-7002 and can also be accessed through its website. BCG operates from 80 State Street, Albany, NY 12207, US.
-
How many shares of BCG are traded daily?
-
The average number of BCG shares traded daily for last 3 months was 52.57K.
-
What is the market cap of BCG currently?
-
The market value of BCG currently stands at $23.03M with its latest stock price at $1.37